PMC:7558914 / 622-769 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"43","span":{"begin":0,"end":18},"obj":"Chemical"},{"id":"66","span":{"begin":92,"end":111},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D006886"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D012140"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Hydroxychloroquine in monotherapy was the most frequent antiviral drug recommended for mild respiratory illness with clinical risk factors (33.3%)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":92,"end":111},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002086"}],"text":"Hydroxychloroquine in monotherapy was the most frequent antiviral drug recommended for mild respiratory illness with clinical risk factors (33.3%)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":0,"end":147},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hydroxychloroquine in monotherapy was the most frequent antiviral drug recommended for mild respiratory illness with clinical risk factors (33.3%)."}